You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sinclair, Inc. (SBGI) - free report >>
Aquestive Therapeutics, Inc. (AQST) - free report >>
Garrett Motion Inc. (GTX) - free report >>
Image: Bigstock
New Strong Buy Stocks for May 9th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Sinclair Broadcast Group, Inc. (SBGI - Free Report) : This media company has seen the Zacks Consensus Estimate for its current year earnings increasing 87.5% over the last 60 days.
Sinclair Broadcast Group, Inc. Price and Consensus
Sinclair Broadcast Group, Inc. price-consensus-chart | Sinclair Broadcast Group, Inc. Quote
Aquestive Therapeutics, Inc. (AQST - Free Report) : This pharmaceutical company has seen the Zacks Consensus Estimate for its next year earnings increasing 55.2% over the last 60 days.
Aquestive Therapeutics, Inc. Price and Consensus
Aquestive Therapeutics, Inc. price-consensus-chart | Aquestive Therapeutics, Inc. Quote
Playtika Holding Corp. (PLTK - Free Report) : This mobile game developer has seen the Zacks Consensus Estimate for its current year earnings increasing 8.9% over the last 60 days.
Playtika Holding Corp. Price and Consensus
Playtika Holding Corp. price-consensus-chart | Playtika Holding Corp. Quote
Garrett Motion Inc. (GTX - Free Report) : This turbocharger and electric-boosting technology company for light and commercial vehicle original equipment manufacturers has seen the Zacks Consensus Estimate for its current year earnings increasing 8.7% over the last 60 days.
Garrett Motion Inc. Price and Consensus
Garrett Motion Inc. price-consensus-chart | Garrett Motion Inc. Quote
Larimar Therapeutics, Inc. (LRMR - Free Report) : This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 47.8% over the last 60 days.
Larimar Therapeutics, Inc. Price and Consensus
Larimar Therapeutics, Inc. price-consensus-chart | Larimar Therapeutics, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.